Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nutrition and dietary supplements in age-related macular degeneration.

Die Ophthalmologie·2026
Same author

Evaluation of aggressive posterior retinopathy of prematurity (AP-ROP) in the German Retina.net ROP registry.

Frontiers in medicine·2026
Same author

Mitochondrial damage drives T-cell immunometabolic paralysis after major surgery.

EMBO molecular medicine·2025
Same author

Neovascular Age-Related Macular Degeneration and GLP-1 RAs.

JAMA ophthalmology·2025
Same author

[Nutrition and dietary supplements in age-related macular degeneration].

Die Ophthalmologie·2025
Same author

[Artificial Intelligence in Retinology].

Klinische Monatsblatter fur Augenheilkunde·2025
Same journal

Corneal Neurotisation in Neurotrophic Keratopathy: A Retrospective Analysis of Functional Outcomes and Clinical Courses.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Imbalanced Trace Elements as Risk Factors in the Pathogenesis of Glaucoma.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Impact of Wearing a Face Mask on the Reliability of Standard Automated Perimetry in Glaucoma Patients and Suspects: a Retrospective Longitudinal Study.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

[Siderotic Cataract Eight Months After Intralenticular Metallic Foreign Body: A Case Report and Surgical Management].

Klinische Monatsblatter fur Augenheilkunde·2026
See all related articles

Related Experiment Video

Updated: Oct 25, 2025

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.3K

[Diabetic Macular Edema].

Teresa Barth, Horst Helbig

    Klinische Monatsblatter Fur Augenheilkunde
    |August 11, 2021
    PubMed
    Summary
    This summary is machine-generated.

    Intravitreal anti-VEGF therapy is standard for diabetic macular edema (DME), offering vision improvement. Corticosteroids are alternatives, but anti-VEGF is preferred over laser therapy for DME.

    More Related Videos

    Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
    10:14

    Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

    Published on: May 26, 2023

    3.8K
    Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
    05:54

    Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

    Published on: January 24, 2025

    451

    Related Experiment Videos

    Last Updated: Oct 25, 2025

    Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
    04:36

    Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

    Published on: January 12, 2024

    1.3K
    Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
    10:14

    Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

    Published on: May 26, 2023

    3.8K
    Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
    05:54

    Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

    Published on: January 24, 2025

    451

    Area of Science:

    • Ophthalmology
    • Retinal Diseases
    • Diabetic Retinopathy

    Background:

    • Diabetic macular edema (DME) is a chronic retinal condition necessitating diligent monitoring.
    • Intravitreal anti-VEGF therapy is now the standard for center-involving DME, improving and stabilizing vision.
    • Intravitreal corticosteroids offer comparable visual outcomes with less frequent injections but carry risks like cataract and glaucoma progression, positioning them as second-line treatments.

    Purpose of the Study:

    • To review current therapeutic strategies for diabetic macular edema (DME).
    • To compare the efficacy and indications of anti-VEGF therapy, corticosteroids, focal laser, and surgery for DME.
    • To highlight considerations for anti-VEGF treatment in ischemic maculopathy and the role of fluorescein angiography.

    Main Methods:

    • Review of current literature and clinical guidelines on DME management.
    • Comparison of treatment modalities including intravitreal anti-VEGF, corticosteroids, focal laser photocoagulation, and vitrectomy.
    • Analysis of factors influencing treatment decisions, such as disease severity, ischemia, and patient-specific conditions.

    Main Results:

    • Intravitreal anti-VEGF therapy is the established first-line treatment for center-involving DME.
    • Long-acting intravitreal corticosteroids provide similar visual results but are reserved for specific cases due to side effects.
    • Focal laser photocoagulation is no longer a primary therapy but may be used in select situations. Vitrectomy is indicated for tractional macular edema.

    Conclusions:

    • Anti-VEGF therapy is the preferred treatment for DME, with corticosteroids as a second-line option.
    • Treatment decisions for DME should consider visual acuity, OCT, and fluorescein angiography, especially in cases of ischemia.
    • Surgical intervention (vitrectomy) is reserved for DME associated with tractional components like epiretinal membranes.